You are here
Canada House Wellness Group awarded a dispensary license in Edmonton
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES
TORONTO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Canada House Wellness Group Inc. (“Canada House - CSE: CHV”), one of Canada’s leading vertically integrated provider of medical cannabis products and services, is pleased to announce that it has won a dispensary license from the City of Edmonton through its lottery system. This license will allow for the launch of the non-medical distribution of cannabis and the exploration of other distribution channel opportunities.
The Edmonton based dispensary will have a separate brand identity and is a key component of Canada House’s consulting initiatives, in partnership with Medicine Man Technologies Inc. (OTCQB: MDCL) of Colorado. Not only does this enhance awareness of Canada House by potential micro-grower customers and other Licensed Producers, it should provide new insights into cannabis end users, further expanding Canada House’s licensing and cultivation expertise.
“Canada House is a medical cannabinoid therapy company at the core,” said CHV CEO Chris Churchill-Smith. “We are reviewing and studying the recreational cannabis market and what role CHV can play in it while staying true to our core strategy of providing leading medical cannabinoid therapy products and services. This license allows us to carefully and responsibly test this subsegment of the market while keeping focused on the execution of our clinical strategy. Building on CHV's in-depth understanding of the medical cannabis market, the dispensary enhances CHV's insight and knowledge of the overall cannabis industry by allowing CHV to also track meaningful trends in the recreational market, creating the opportunity to place premium cannabis in both markets.”
Canada House Wellness Group Inc.
Canada House is an experienced, integrated medical cannabis company providing patient-specific cannabinoid therapy products and services through its clinics and licensed producer. Canada House is the parent company of Marijuana for Trauma Inc., Knalysis Technologies and Abba Medix Corp. For more information please visit http://www.canadahouse.ca or www.sedar.com.
For further information, please contact:
Boom Capital Markets
Canada House Wellness Group Inc.
Chris Churchill-Smith, CEO
Cautionary Statement Regarding Forward Looking Information. This press release contains forward-looking statements, including statements that relate to, among other things, the Company’s clinic, production and technology businesses, its future plans, the Company’s markets, objectives, goals, strategies, intentions, beliefs, expectations and estimates, and can generally be identified by the use of words such as “may”, “will”, “could”, “should”, “would”, “likely”, "possible", “expect”, “intend”, “estimate”, “anticipate”, “believe”, “plan”, “objective” and “continue” (or the negative thereof) and words and expressions of similar import. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, such statements involve risks and uncertainties, and undue reliance should not be placed on such statements. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. Material assumptions used to develop forward-looking information in this news release include, among other things, the regulations related to cannabis use under the Access to Cannabis for Medical Purposes Regulations and the act respecting cannabis and to amend the Controlled Drugs and Substances Act, the Criminal Code and other Acts, passed by the Canadian Federal government, making cannabis legal for recreational use by October 17, 2018; Company liquidity and capital resources, including the availability of additional capital resources to fund its activities; level of competition; the ability to adapt products and services to the changing market; the ability to attract and retain key executives; and the ability to execute strategic plans. Additional information about material factors that could cause actual results to differ materially from expectations and about material factors or assumptions applied in making forward-looking statements may be found in the Company’s most recent annual and interim Management’s Discussion and Analysis under “Risk and Uncertainties” as well as in other public disclosure documents filed with Canadian securities regulatory authorities. The Company does not undertake any obligation to update publicly or to revise any of the forward-looking statements contained in this document, whether as a result of new information, future events or otherwise, except as required by law.”
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.